Morgan Stanley’s Jin Medical International ZJYL Stock Holding History

Morgan Stanley’s Portfolio ZJYL Stock Details ZJYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5	Closed	-$22	–	8530
2025 Q4	$22	Sell	5 -5	-50%	-$29	﹤0.01%	8071
2025 Q3	$113	Buy	+10	New	+$128	﹤0.01%	7668
2025 Q2	–	Sell	-46	Closed	-$691	–	8290
2025 Q1	$691	Buy	46 +29	+171%	+$482	﹤0.01%	7332
2024 Q4	$264	Sell	17 -88	-84%	-$2.76K	﹤0.01%	7393
2024 Q3	$5.67K	Sell	105 -42	-29%	-$2.53K	﹤0.01%	6880
2024 Q2	$7.63K	Buy	147 +60	+69%	+$3.79K	﹤0.01%	6751
2024 Q1	$6.67K	Buy	+87	New	+$12.7K	﹤0.01%	6819

Other funds holding ZJYL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's ZJYL Position: Q1 2026 in Review

Morgan Stanley sold out of Jin Medical International (ZJYL) in Q1 2026, closing a stake of 5 shares — an estimated $22 sold.

Morgan Stanley first reported a position in ZJYL in Q1 2024 and held it in 7 quarters. The position peaked at $7.63K in Q2 2024. 2 funds tracked by Wall St. Rank hold ZJYL as of Q1 2026.

Morgan Stanley reported no remaining Jin Medical International position as of Q1 2026 after selling out during the quarter.
Morgan Stanley sold 5 Jin Medical International shares in Q1 2026, an estimated $22.
Morgan Stanley first reported a position in Jin Medical International in Q1 2024 and held it in 7 quarters.
Morgan Stanley's Jin Medical International position peaked at $7.63K in Q2 2024.
2 funds tracked by Wall St. Rank held Jin Medical International as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.